EROX — Human Pheromone Sciences Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
Annual cashflow statement for Human Pheromone Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.111 | -0.016 | -0.239 | -0.284 | -0.097 |
| Depreciation | |||||
| Non-Cash Items | 0.056 | 0.098 | 0.08 | 0.04 | 0.015 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.54 | -0.585 | -0.372 | -0.314 | -0.177 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 1.49 | -0.501 | -0.53 | -0.557 | -0.258 |
| Capital Expenditures | 0 | -0.003 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.003 | 0 | 0 | 0 |
| Financing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Cash from Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.49 | -0.504 | -0.53 | -0.557 | -0.258 |